Page last updated: 2024-12-10

ethylenediamine platinum(ii) malonate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID3035205
MeSH IDM0115452

Synonyms (20)

Synonym
ethylenediammineplatinum(ii) malonate
nsc 146068
(ethane-1,2-diamine-n,n')(malonato(2-)-o,o')platinum
malpen
einecs 255-484-8
platinum, (1,2-ethanediamine-kappan,kappan')(propanedioato(2-)-kappao1,kappao3)-, (sp-4-2)-
platinum, (1,2-ethanediamine-n,n')(propanedioato(2-)-o,o')-, (sp-4-2)-
platinum (ii), (ethylenediammine)malonato-
jm-40
ethylenediamine platinum(ii) malonate
unii-9bt36e343a
jm 40
malopen
9bt36e343a ,
(sp-4-2)-(1,2-ethanediamine-.kappa.n1,.kappa.n2)(propanedioato(2-)-.kappa.o1,.kappa.o3)platinum
malonatoethylenediamineplatinum(ii)
platinum, (1,2-ethanediamine-.kappa.n,.kappa.n')(propanedioato(2-)-.kappa.o1,.kappa.o3)-, (sp-4-2)-
platinum, (1,2-ethanediamine-.kappa.n1,.kappa.n2)(propanedioato(2-)-.kappa.o1,.kappa.o3)-, (sp-4-2)-
(ethane-1,2-diamine-n,n')[malonato(2-)-o,o']platinum
Q27895836

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" Calculated pharmacokinetic parameters (peak concentrations, half-lives, areas under the curve) were compared with the corresponding values in patients at the maximal tolerated dose."( Comparative pharmacokinetics of cisplatin and three analogues in mice and humans.
Elferink, F; Klein, I; Pinedo, HM; van der Vijgh, WJ; van Hennik, MB; Vermorken, JB; Winograd, B, 1987
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.15

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.15 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.15)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]